MSAA Announces New Chief Medical Officer

The Multiple Sclerosis Association of America (MSAA) is proud to announce a new Chief Medical Officer (CMO) for the organization. Barry A. Hendin, a highly accomplished neurologist who specializes in MS, has assumed the role. Preceding Dr. Hendin was Jack Burks, MD, a clinical professor of neurology for the Herbert Wertheim College of Medicine at […]

Read News Article

What’s New in MS Research: July 2019

The effort to enhance the lives and health of people with multiple sclerosis (MS) is advancing on many fronts, as researchers explore the impact of approaches ranging from stress management, exercise, diet, stem-cell therapy, and cannabis use, to a variety of approved and investigational disease-modifying therapies (DMTs).

This latest edition of “What’s New in MS Research” features highlights from the annual meetings of the American Academy of Neurology (AAN) and the Consortium of Multiple Sclerosis Centers (CMSC), both held in May of this year.

Read News Article

MSAA Offers a Free Online Support Forum to Connect Members of the MS Community

The Multiple Sclerosis Association of America’s (MSAA) free online support forum, My MSAA Community, has been a continued source of support, encouragement, and hope for members of the multiple sclerosis (MS) community since the Summer of 2016. Powered by HealthUnlocked, My MSAA Community was created to offer people with multiple sclerosis, care partners, friends, and family members a way to connect with others also affected by the condition.

Read News Article

MSAA’s Blog and Publications Recognized by Healthline and the Digital Health Awards

The Multiple Sclerosis Association of America (MSAA) is pleased to announce that our blog, MS Conversations, has been named one of the Best Multiple Sclerosis Blogs for the fifth consecutive year by Healthline! Each year, Healthline selects blogs that, “lead the way by advocating, informing, and getting real about MS.” Healthline also notes that MS […]

Read News Article

Understanding Multiple Sclerosis: A New Video Series from the Multiple Sclerosis Association of America

The Multiple Sclerosis Association of America (MSAA) in partnership with @Point of Care, is proud to announce a new video series titled “Understanding Multiple Sclerosis.” This 12-part video series, featuring expert neurologist Dr. Michelle Fabian, provides an overview of the MS process, possible causes, symptoms, treatments, wellness strategies, and more. Each video offers valuable insights and up-to-date information in a relaxed, conversational style that is easy to understand and follow.

Read News Article
MSAA Art Showcase 2019

MSAA Recognizes Ten Years of Artwork from Individuals with Multiple Sclerosis

Started in 2009, the MSAA Art Showcases are comprised of two categories: the MS Ability Art Showcase and the Four Seasons Art Showcase. Artists with a diagnosis of MS are invited each fall to submit their best oil, watercolor, acrylic or pastel paintings, as well as drawings in ink or pencil. The artwork debuts on MSAA’s website, alongside the artists’ personal stories during MS Awareness Month every March.

Read News Article

Mavenclad® (Cladribine) Tablets Approved by the FDA for Adults with Relapsing Forms of MS, Including Active SPMS

In a news release dated March 29, 2019, the United States Food and Drug Administration (FDA) announced the approval of Mavenclad® (cladribine) oral tablets to treat adults with relapsing forms of multiple sclerosis (MS). The approval is for individuals with relapsing-remitting MS (RRMS) and for individuals with active secondary-progressive MS (SPMS).

Read News Article

Mayzent® (Siponimod) Tablets Approved by the FDA for Adults with Relapsing Forms of MS, Including Active SPMS

In a news release dated March 26, 2019, the United States Food and Drug Administration (FDA) announced the approval of Mayzent® (siponimod) oral tablets to treat adults with relapsing forms of multiple sclerosis (MS). The approval includes individuals with clinically isolated syndrome, relapsing-remitting MS (RRMS), and active secondary-progressive MS (SPMS). Mayzent is the only disease-modifying […]

Read News Article

What’s New in MS Research: March 2019

The opening months of 2019 saw significant research advances on many fronts in multiple sclerosis (MS). A sophisticated analysis of data using healthcare claims found that the number of people in the United States living with MS is more than twice as high as previously estimated. Dietary studies sounded a cautionary note for people with MS drinking soda and many other sweetened beverages, and a hopeful note on the potential for flavonoid-rich cocoa to reduce MS-associated fatigue. A promising stem-cell therapy is moving forward in the clinical-trials process, while the FDA is considering whether to approve a new disease-modifying therapy (DMT).

Read News Article

Multiple Sclerosis Association of America Focuses 2019 MS Awareness Month Campaign on MS and the Family

The Multiple Sclerosis Association of America (MSAA) is proud to recognize March as Multiple Sclerosis (MS) Awareness Month. This year, MSAA’s awareness campaign focuses on MS and the Family, with specific topics addressing: Relationships and MS, and Spotlighting Care Partner Needs. MSAA invites you to participate in weekly awareness activities, which include: Relationships and MS […]

Read News Article